These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 25434191)

  • 21. High-dose pergolide monotherapy in the treatment of severe levodopa-induced dyskinesias.
    Facca A; Sanchez-Ramos J
    Mov Disord; 1996 May; 11(3):327-9. PubMed ID: 8723153
    [No Abstract]   [Full Text] [Related]  

  • 22. Parkinson disease treatment in hospitals and nursing facilities: avoiding pitfalls.
    Ahlskog JE
    Mayo Clin Proc; 2014 Jul; 89(7):997-1003. PubMed ID: 24996235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levodopa/carbidopa to improve motor function subsequent to brain tumor excision.
    Ennis JD; Harvey D; Ho E; Chari V; Graham A; Nesathurai S
    Am J Phys Med Rehabil; 2013 Apr; 92(4):307-11. PubMed ID: 23221674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopaminergic functional supersensitivity: effects of chronic L-dopa and carbidopa treatment in an animal model of Parkinson's disease.
    Hossain MA; Weiner N
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1105-11. PubMed ID: 8263772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beneficial anti-Parkinson effects of camel milk in Chlorpromazineinduced animal model: Behavioural and histopathological study.
    Khatoon H; Najam R; Mirza T; Sikandar B
    Pak J Pharm Sci; 2016 Sep; 29(5):1525-1529. PubMed ID: 27731807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serotonin syndrome in stroke patients.
    Jang SH; Kwon YM; Chang MC
    J Rehabil Med; 2015 Mar; 47(3):282-5. PubMed ID: 25483226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacotherapy: problems and practices.
    Muenter MD
    Clin Neuropharmacol; 1986; 9 Suppl 1():S23-36. PubMed ID: 3708606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delayed chorea after recovery from severe akinetic-rigid parkinsonism caused by extrapontine myelinolysis.
    Noda K; Tosaka Y; Ishiguro Y; Kawajiri S; Tomizawa Y; Hattori N; Okuma Y
    J Neurol Sci; 2015 Nov; 358(1-2):498-500. PubMed ID: 26384614
    [No Abstract]   [Full Text] [Related]  

  • 30. Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions.
    Murer MG; Dziewczapolski G; Menalled LB; García MC; Agid Y; Gershanik O; Raisman-Vozari R
    Ann Neurol; 1998 May; 43(5):561-75. PubMed ID: 9585350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine receptor agonists reverse behavioral abnormalities of alpha-synuclein transgenic mouse, a new model of Parkinson's disease.
    Wakamatsu M; Iwata S; Funakoshi T; Yoshimoto M
    J Neurosci Res; 2008 Feb; 86(3):640-6. PubMed ID: 17896793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antidopaminergic effects of leucine and genistein on shizophrenic rat models.
    Suresh P; Raju AB
    Neurosciences (Riyadh); 2013 Jul; 18(3):235-41. PubMed ID: 23887213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Entacapone enhances levodopa-induced reversal of motor disability in MPTP-treated common marmosets.
    Smith LA; Gordin A; Jenner P; Marsden CD
    Mov Disord; 1997 Nov; 12(6):935-45. PubMed ID: 9399218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unwanted effects and interaction of intrajejunal levodopa/carbidopa administration.
    Jost WH
    Expert Opin Drug Saf; 2014 Apr; 13(4):447-58. PubMed ID: 24611456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delayed onset of prepulse inhibition deficits following kainic acid treatment on postnatal day 7 in rats.
    Howland JG; Hannesson DK; Phillips AG
    Eur J Neurosci; 2004 Nov; 20(10):2639-48. PubMed ID: 15548207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parcopa: a rapidly dissolving formulation of carbidopa/levodopa.
    Med Lett Drugs Ther; 2005 Jan; 47(1201):12. PubMed ID: 15706700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic administration of risperidone in a rat model of schizophrenia: a behavioural, morphological and molecular study.
    Castellano O; Arji M; Sancho C; Carro J; Riolobos AS; Molina V; Gómez-Nieto R; de Anchieta de Castro E Horta J; Herrero-Turrión MJ; López DE
    Behav Brain Res; 2013 Apr; 242():178-90. PubMed ID: 23291154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe gastrointestinal complications in patients with levodopa/carbidopa intestinal gel infusion.
    Klostermann F; Jugel C; Bömelburg M; Marzinzik F; Ebersbach G; Müller T
    Mov Disord; 2012 Nov; 27(13):1704-5. PubMed ID: 23192929
    [No Abstract]   [Full Text] [Related]  

  • 39. Prospective assessment of peripheral neuropathy in Duodopa-treated parkinsonian patients.
    Merola A; Zibetti M; Rizzone MG; Troiano M; Artusi CA; Angrisano S; Cocito D; Lopiano L
    Acta Neurol Scand; 2014 Jan; 129(1):e1-5. PubMed ID: 23834498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of enteric-coated levodopa with levodopa-carbidopa combination. A double-blind crossover trial.
    Gilligan B; Wodak J; Stark R; O'Halloran M
    Med J Aust; 1979 Aug; 2(4):205-7. PubMed ID: 390336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.